A ngiography has been used to monitor the effects of thrombolytic therapy on coronary artery anatomy and flow during the early hours of acute of myocardial infarction since the early 1980s.1-3 Several early investigators noted a spectrum of responses of initially occluded coronary arteries to thrombolytic therapy using angiographic assessment. (TEAM-3) .17 Because the clinical outcomes after anistreplase and alteplase-the two thrombolytic treatment regimens used in this studywere similar, the authors were able to combine both treatment groups in this evaluation of TIMI perfusion grades. Using entry criteria that are similar to those for most recent studies of thrombolytic therapy in acute myocardial infarction, patients were treated with one of the thrombolytic agents within 4 hours of onset of chest pain. Infarct artery patency was studied approximately 30 hours after entry. Three patency groups were defined for statistical comparisons: grades 0 and 1 were considered perfusion failure, grade 3 was considered complete perfusion, and grade 2 was considered partial perfusion. Radionuclide ventricular angiography was performed at hospital discharge and a mean of 1 month after entry. At both hospital discharge and 1-month evaluations, patients with grade 3 perfusion had significantly better left ventricular ejection fraction (globally and within the infarct region) than did patients with TIMI grade 0 or 1 or TIMI grade 2 perfusion. According to hospital discharge ECG QRS scoring, patients with grade 3 perfusion demonstrated a significantly lower QRS score than those with grades 0 or 1 or grade 2 perfusion. Peak and time-to-peak lactate dehydrogenase (LDH) values were lower in patients with grade 3 perfusion. In a subset of patients, time-release LDH and LDH-1 isoenzyme kinetic curves could be constructed, and lesser amounts of LDH and LDH-1 were released in patients with TIMI grade 3 perfusion. Finally, there was a trend toward lesser morbidity in patients with grade 3 perfusion than in those with grades 0 or 1 or grade 2 perfusion. In this analysis based on TIMI grade perfusion assessed at 30 hours after initiation of thrombolytic treatment, the authors conclude that "patients with grade 3 flow differ significantly from those having grades 0/1 and 2 (flow),
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